BIO-TECHNE Corp Noncontrolling Interest, Decrease from Deconsolidation
BIO-TECHNE Corp (TECH) reported Noncontrolling Interest, Decrease from Deconsolidation of $613.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2024-05-06.
Discontinued › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation · last filed 2024-05-06
- BIO-TECHNE Corp noncontrolling interest, decrease from deconsolidation for the quarter ending 2022-09-30 was $613.00K.
| Period end | Noncontrolling Interest, Decrease from Deconsolidation 3 month |
|---|---|
| 2022-09-30 | $613.00K 10-Q · filed 2024-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |